|
1
|
Wachtel EV and Hendricks-Muñoz KD: Current
management of the infant who presents with neonatal encephalopathy.
Curr Probl Pediatr Adolesc Health Care. 41:132–153. 2011.
View Article : Google Scholar
|
|
2
|
Selway LD: State of the science: Hypoxic
ischemic encephalopathy and hypothermic intervention for neonates.
Adv Neonatal Care. 10:60–68. 2010. View Article : Google Scholar
|
|
3
|
Robertson CM, Finer NN and Grace MG:
School performance of survivors of neonatal encephalopathy
associated with birth asphyxia at term. J Pediatr. 114:753–760.
1989. View Article : Google Scholar
|
|
4
|
Marlow N, Rose AS, Rands CE and Draper ES:
Neuropsychological and educational problems at school age
associated with neonatal encephalopathy. Arch Dis Child Fetal
Neonatal Ed. 90:F380–F387. 2005. View Article : Google Scholar :
|
|
5
|
Back SA, Han BH, Luo NL, Chricton CA,
Xanthoudakis S, Tam J, Arvin KL and Holtzman DM: Selective
vulnerability of late oligodendrocyte progenitors to
hypoxia-ischemia. J Neurosci. 22:455–463. 2002.
|
|
6
|
Li L, Klebe D, Doycheva D, McBride DW,
Krafft PR, Flores J, Zhou C, Zhang JH and Tang J: G-CSF ameliorates
neuronal apoptosis through GSK-3β inhibition in neonatal
hypoxia-ischemia in rats. Exp Neurol. 263:141–149. 2015. View Article : Google Scholar
|
|
7
|
Xiao Q, Ford AL, Xu J, Yan P, Lee KY,
Gonzales E, West T, Holtzman DM and Lee JM: Bcl-x pre-mRNA splicing
regulates brain injury after neonatal hypoxia-ischemia. J Neurosci.
32:13587–13596. 2012. View Article : Google Scholar :
|
|
8
|
Mihaly SR, Ninomiya-Tsuji J and Morioka S:
TAK1 control of cell death. Cell Death Differ. 21:1667–1676. 2014.
View Article : Google Scholar :
|
|
9
|
Yamaguchi K, Shirakabe K, Shibuya H, Irie
K, Oishi I, Ueno N, Taniguchi T, Nishida E and Matsumoto K:
Identification of a member of the MAPKKK family as a potential
mediator of TGF-beta signal transduction. Science. 270:2008–2011.
1995. View Article : Google Scholar
|
|
10
|
Sato S, Sanjo H, Takeda K, Ninomiya-Tsuji
J, Yamamoto M, Kawai T, Matsumoto K, Takeuchi O and Akira S:
Essential function for the kinase TAK1 in innate and adaptive
immune responses. Nat Immunol. 6:1087–1095. 2005. View Article : Google Scholar
|
|
11
|
Hirata Y, Sugie A, Matsuda A, Matsuda S
and Koyasu S: TAK1-JNK axis mediates survival signal through Mcl1
stabilization in activated T cells. J Immunol. 190:4621–4626.
2013.
|
|
12
|
Wang JS, Wu D, Huang DY and Lin WW: TAK1
inhibition-induced RIP1-dependent apoptosis in murine macrophages
relies on constitutive TNF-α signaling and ROS production. J Biomed
Sci. 22:762015. View Article : Google Scholar :
|
|
13
|
Augeri DJ, Langenfeld E, Castle M,
Gilleran JA and Langenfeld J: Inhibition of BMP and of TGFβ
receptors downregulates expression of XIAP and TAK1 leading to lung
cancer cell death. Mol Cancer. 15:272016. View Article : Google Scholar :
|
|
14
|
Lin P, Niu W, Peng C, Zhang Z and Niu J:
The role of TAK1 expression in thyroid cancer. Int J Clin Exp
Pathol. 8:14449–14456. 2015.
|
|
15
|
Okada M, Matsuzawa A, Yoshimura A and
Ichijo H: The lysosome rupture-activated TAK1-JNK pathway regulates
NLRP3 inflammasome activation. J Biol Chem. 289:32926–32936. 2014.
View Article : Google Scholar :
|
|
16
|
Bao D, Lu D, Liu N, Dong W, Lu YD, Qin C
and Zhang LF: Tomoregulin-1 prevents cardiac hypertrophy after
pressure overload in mice by inhibiting TAK1-JNK pathways. Dis
Model Mech. 8:795–804. 2015. View Article : Google Scholar :
|
|
17
|
Fan Y, Cheng J, Vasudevan SA, Patel RH,
Liang L, Xu X, Zhao Y, Jia W, Lu F, Zhang H, et al: TAK1 inhibitor
5Z-7-oxozeaenol sensitizes neuroblastoma to chemotherapy.
Apoptosis. 18:1224–1234. 2013. View Article : Google Scholar :
|
|
18
|
Hayakawa Y, Hirata Y, Kinoshita H,
Sakitani K, Nakagawa H, Nakata W, Takahashi R, Sakamoto K, Maeda S
and Koike K: Differential roles of ASK1 and TAK1 in Helicobacter
pylori-induced cellular responses. Infect Immun. 81:4551–4560.
2013. View Article : Google Scholar :
|
|
19
|
Ikeda Y, Morioka S, Matsumoto K and
Ninomiya-Tsuji J: TAK1 binding protein 2 is essential for liver
protection from stressors. PLoS One. 9:e880372014. View Article : Google Scholar :
|
|
20
|
Hagberg H, Mallard C, Rousset CI and
Xiaoyang W: Apoptotic mechanisms in the immature brain: Involvement
of mitochondria. J Child Neurol. 24:1141–1146. 2009. View Article : Google Scholar :
|
|
21
|
Zhu C, Qiu L, Wang X, Hallin U, Candé C,
Kroemer G, Hagberg H and Blomgren K: Involvement of
apoptosis-inducing factor in neuronal death after hypoxia-ischemia
in the neonatal rat brain. J Neurochem. 86:306–317. 2003.
View Article : Google Scholar
|
|
22
|
Hagberg H, Wilson MA, Matsushita H, Zhu C,
Lange M, Gustavsson M, Poitras MF, Dawson TM, Dawson VL,
Northington F and Johnston MV: PARP-1 gene disruption in mice
preferentially protects males from perinatal brain. J Neurochem.
90:1068–1075. 2004. View Article : Google Scholar
|
|
23
|
Zhu C, Wang X, Deinum J, Huang Z, Gao J,
Modjtahedi N, Neagu MR, Nilsson M, Eriksson PS, Hagberg H, et al:
Cyclophilin A participates in the nuclear translocation of
apoptosis-inducing factor in neurons after cerebra l
hypoxia-ischemia. J Exp Med. 204:1741–1748. 2007. View Article : Google Scholar :
|
|
24
|
Gu Y, Zhang Y, Bi Y, Liu J, Tan B, Gong M,
Li T and Chen J: Mesenchymal stem cells suppress neuronal apoptosis
and decrease IL-10 release via the TLR2/NFkB pathway in rats with
hypoxic-ischemic brain damage. Mol Brain. 8:652015. View Article : Google Scholar :
|
|
25
|
Sun MY, Cui KJ, Yu MM, Zhang H, Peng XL
and Jiang H: Bax inhibiting peptide reduces apoptosis in neonatal
rat hypoxic-ischemic brain damage. Int J Clin Exp Pathol.
8:14701–14708. 2015.
|
|
26
|
Neubert M, Ridder DA, Bargiotas P, Akira S
and Schwaninger M: Acute inhibition of TAK1 protects against
neuronal death in cerebral ischemia. Cell Death Differ.
18:1521–1530. 2011. View Article : Google Scholar :
|
|
27
|
White BJ, Tarabishy S, Venna VR, Manwani
B, Benashski S, McCullough LD and Li J: Protection from cerebral
ischemia by inhibition of TGFβ-activated kinase. Exp Neurol.
237:238–245. 2012. View Article : Google Scholar :
|
|
28
|
Zhang D, Hu Y, Sun Q, Zhao J, Cong Z, Liu
H, Zhou M, Li K and Hang C: Inhibition of transforming growth
factor beta-activated kinase 1 confers neuroprotection after
traumatic brain injury in rats. Neuroscience. 238:209–217. 2013.
View Article : Google Scholar
|
|
29
|
Cao J, Semenova MM, Solovyan VT, Han J,
Coffey ET and Courtney MJ: Distinct requirements for p38alpha and
c-Jun N-terminal kinase stress-activated protein kinases in
different forms of apoptotic neuronal death. J Biol Chem.
279:35903–35913. 2004. View Article : Google Scholar
|
|
30
|
Tu YF, Tsai YS, Wang LW, Wu HC, Huang CC
and Ho CJ: Overweight worsens apoptosis, neuroinflammation and
blood-brain barrier damage after hypoxic ischemia in neonatal brain
through JNK hyperactivation. J Neuroinflammation. 8:402011.
View Article : Google Scholar :
|
|
31
|
Li D, Li X, Wu J, Li J, Zhang L, Xiong T,
Tang J, Qu Y and Mu D: Involvement of the JNK/FOXO3a/Bim pathway in
neuronal apoptosis after Hypoxic-Ischemic brain damage in neonatal
rats. PLoS One. 10:e01329982015. View Article : Google Scholar :
|
|
32
|
Nijboer CH, Bonestroo HJ, Zijlstra J,
Kavelaars A and Heijnen CJ: Mitochondrial JNK phosphorylation as a
novel therapeutic target to inhibit neuroinflammation and apoptosis
after neonatal ischemic brain damage. Neurobiol Dis. 54:432–444.
2013. View Article : Google Scholar
|
|
33
|
Nijboer CH, van der Kooij MA, van Bel F,
Ohl F, Heijnen CJ and Kavelaars A: Inhibition of the JNK/AP-1
pathway reduces neuronal death and improves behavioral outcome
after neonatal hypoxic-ischemic brain injury. Brain Behav Immun.
24:812–821. 2010. View Article : Google Scholar
|
|
34
|
Tan L, Nomanbhoy T, Gurbani D, Patricelli
M, Hunter J, Geng J, Herhaus L, Zhang J, Pauls E, Ham Y, et al:
Discovery of type II inhibitors of TGFβ-activated kinase 1 (TAK1)
and mitogen-activated protein kinase kinase kinase kinase 2
(MAP4K2). J Med Chem. 58:183–196. 2015. View Article : Google Scholar
|
|
35
|
Wang Z and Zhang H, Shi M, Yu Y, Wang H,
Cao WM, Zhao Y and Zhang H: TAK1 inhibitor NG25 enhances
doxorubicin-mediated apoptosis in breast cancer cells. Sci Rep.
6:327372016. View Article : Google Scholar :
|
